| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 06/07/2006 | EP1666466A2 Mutilin derivatives and their use as Antimicrobials |
| 06/07/2006 | EP1666454A1 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 06/07/2006 | EP1666453A1 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 06/07/2006 | EP1664041A1 Phenyl-carboxamide compounds useful for treating pain |
| 06/07/2006 | EP1664031A2 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors |
| 06/07/2006 | EP1664018A1 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 |
| 06/07/2006 | EP1664016A2 Therapeutic agents useful for treating pain |
| 06/07/2006 | EP1663979A1 Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists |
| 06/07/2006 | EP1663978A2 Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions |
| 06/07/2006 | EP1663977A2 2-pyridinone derivatives, having hiv inhibiting properties |
| 06/07/2006 | EP1663976A1 4-pyridinylmethyl sulfonamide derivatives as fungicidal plant protection agents |
| 06/07/2006 | EP1663974A1 2-pyridone derivatives as netrophil elastase inhibitors and their use |
| 06/07/2006 | EP1663973A1 2-pyridone derivatives as neutrophil elastase inhibitors and their use |
| 06/07/2006 | EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 06/07/2006 | EP1663958A2 Haloalkyl containing compounds as cysteine protease inhibitors |
| 06/07/2006 | EP1663953A1 Inhibitors of histone deacetylase |
| 06/07/2006 | EP1663936A1 Biaryloxymethylarene-carboxylic acids |
| 06/07/2006 | EP1663234A1 Piperazine derivatives for the treatment of hiv infections |
| 06/07/2006 | EP1663204A2 C-kit modulators and methods of use |
| 06/07/2006 | EP1585725A4 Compounds which mimic the chemical and biological properties of discodermolide |
| 06/07/2006 | EP1562904B1 Pyridine derivates useful as fragrance materials |
| 06/07/2006 | EP1448577B1 Rhodium and iridium complexes |
| 06/07/2006 | EP1311478B1 Novel (thio)urea compounds and the pharmaceutical compositions containing the same |
| 06/07/2006 | EP1309559B1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 06/07/2006 | CN1784454A Electroluminescent metallo-supramolecules with terpyridine-based groups |
| 06/07/2006 | CN1784380A Novel bioisosteres of actinonin |
| 06/07/2006 | CN1783010A Program code size partitioning system and method for multiple memory multi-processing systems |
| 06/07/2006 | CN1781918A Process for producing thioester compound |
| 06/07/2006 | CN1781903A Process for the preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof |
| 06/07/2006 | CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 06/06/2006 | US7057079 Method of synthesizing alkenone compounds |
| 06/06/2006 | US7057067 Reacting a benzoic acid with a halogenating agent in presence of palladium catalyst to form halogenated benzoic acid or derivatives |
| 06/06/2006 | US7056946 antitumor taxane containing a carboante group at c-10 position, benzoyoxy at c-2 position and hydroxy at c-7 position in the ring (c3o-c6-c6-c8) |
| 06/06/2006 | US7056934 use in treating respiratory system disorders such as asthma, incipient asthma and wheezy infant syndrome, chronic or acute bronchoconstriction, chronic bronchitis, small airways obstruction, emphysema, chronic eosinophilic pneumonia, chronic obstructive pulmonary disease, allergies |
| 06/06/2006 | US7056932 Heterocyclyl substituted 1-alkoxy acetic acid amides |
| 06/06/2006 | US7056926 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, particularly those diseases related to thrombosis |
| 06/06/2006 | US7056909 5,5-Difluoro-3(S)-(pyrimidin-5-yl)-9-(5,6,7,8-tetrahydro-(1, 8)-naphthyridin-2-yl)-nonanoic acid; inhibition of bone resorption, restenosis, angiogenesis, retinopathy, macular degeneration, arthritis, metastatic tumor growth, etc. |
| 06/06/2006 | US7056902 4-dedimethylamino tetracycline compounds |
| 06/06/2006 | US7056376 Printing an image on a substrate comprising applying thereto a formulation comprising a liquid medium and a compound containing azo groups and metallized 1,8-dihydroxynaphthyl group |
| 06/06/2006 | CA2232913C Process for the preparation of azide derivatives |
| 06/06/2006 | CA2178974C Naphthalene derivatives, processes for the preparation thereof, and intermediates therefor |
| 06/06/2006 | CA2163601C 2-aminobenzenesulfonic acid and 2-aminobenzenesulfonyle chloride derivatives |
| 06/06/2006 | CA2136903C Acetic acid derivatives |
| 06/01/2006 | WO2006057961A1 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors |
| 06/01/2006 | WO2006057870A1 Potentiators of glutamate receptors |
| 06/01/2006 | WO2006057868A1 Antithrombotic diamides |
| 06/01/2006 | WO2006057860A1 Potentiators of glutamate receptors |
| 06/01/2006 | WO2006057845A1 Aromatic ether derivatives useful as thrombin inhibitors |
| 06/01/2006 | WO2006057448A1 Arylalkanoic acid derivative |
| 06/01/2006 | WO2006057325A1 Pyrene compound and, utilizing the same, light emitting transistor device and electroluminescence device |
| 06/01/2006 | WO2006057323A1 Composition for amyloid-associated disease diagnosis |
| 06/01/2006 | WO2006056752A1 Phenoxyacetic acid derivatives useful for treating respiratory diseases |
| 06/01/2006 | WO2006056462A1 Azine compounds for combating animal pests |
| 06/01/2006 | WO2006056427A1 Novel 4-arylamino pyridone derivatives as mek inhibitors for the treatment of hyperproliferative disorders |
| 06/01/2006 | WO2006056333A1 Substituted oxyguanidines |
| 06/01/2006 | WO2006030211A3 Acyclic sulphonamides |
| 06/01/2006 | WO2006028523A3 Hydroxypyridinone, hydroxypyridinethione, pyrone, and thiopyrone metalloprotein inhibitors |
| 06/01/2006 | WO2006014918A3 Heterocyclic acetophenone potentiators of metabotropic glutamate receptors |
| 06/01/2006 | US20060116519 Synthesis of 5-bromo-4-methyl-pyridin-3-ylmethyl)-ethyl-carbamic acid tert-butyl ester |
| 06/01/2006 | US20060116418 Materials and methods for treating hypercholesterolemia |
| 06/01/2006 | US20060116394 Fab I inhibitors |
| 06/01/2006 | US20060116388 CXCR3 antagonists |
| 06/01/2006 | US20060116377 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
| 06/01/2006 | US20060116374 substituted bis/thiohydrazide amide compound; synergistic effect with taxol or taxotere, anticancer agents, side effect reduction |
| 06/01/2006 | US20060116356 Phosphonate analogs of HIV integrase inhibitor compounds |
| 06/01/2006 | US20060115815 Method and compositions for identifying anti-hiv therapeutic compounds |
| 06/01/2006 | US20060115425 Antagonists and/or inverse agonists of the Cannabinoid-1 receptor; useful in treatment of central nervous system disorders, psychological disorders, multiple sclerosis, as antiinflammatory agents |
| 06/01/2006 | DE4211694B4 Flüssigkristalline Verbindungen Liquid-crystalline compounds |
| 06/01/2006 | DE102004056626A1 Substituierte Oxyguanidine Substituted oxyguanidines |
| 06/01/2006 | CA2590349A1 Potentiators of glutamate receptors |
| 06/01/2006 | CA2588881A1 Potentiators of glutamate receptors |
| 06/01/2006 | CA2588713A1 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors |
| 06/01/2006 | CA2588607A1 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production |
| 06/01/2006 | CA2588048A1 Substituted oxyguanidines |
| 06/01/2006 | CA2587178A1 Novel 4-arylamino pyridone derivatives as mek inhibitors for the treatment of hyperproliferative disorders |
| 06/01/2006 | CA2587134A1 Azine compounds for combating animal pests |
| 05/31/2006 | EP1661889A1 Chemokine receptor antagonist and medical use thereof |
| 05/31/2006 | EP1661886A1 Insecticide for agricultural or horticultural use and method of use thereof |
| 05/31/2006 | EP1661879A1 Diphenyl ether compound, process for producing the same, and use |
| 05/31/2006 | EP1661569A1 Compounds effecting glucokinase |
| 05/31/2006 | EP1661568A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661567A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661563A1 Compound effecting Glucokinase |
| 05/31/2006 | EP1660609A1 Electroluminescent device |
| 05/31/2006 | EP1660503A1 Naphthalene carboxamides and their derivatives useful as new anti-angiogenic agents |
| 05/31/2006 | EP1660471A1 Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 05/31/2006 | EP1660441A2 N-sulfonyl-alpha-amino-acid derivatives |
| 05/31/2006 | EP1660440A2 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 05/31/2006 | EP1660433A2 Preparation and use of alkylating agents |
| 05/31/2006 | EP1660428A1 Ppar modulators |
| 05/31/2006 | EP1660427A1 Substituted arylalkanoic acid derivative and use thereof |
| 05/31/2006 | EP1659863A2 Pesticidally active phenol derivatives |
| 05/31/2006 | EP1542797B1 Catalyst systems for ethylene oligomerisation to linear alpha olefins |
| 05/31/2006 | EP1527052B1 3-heterocyclyl substituted benzoic acid derivatives |
| 05/31/2006 | EP1461345B1 Copper deposition using copper formate complexes |
| 05/31/2006 | EP1420644B1 Substituted propargylamines |
| 05/31/2006 | EP1383857B1 Use of metal complex compounds as oxidation catalysts |
| 05/31/2006 | EP1296931B1 Polyamine analogues as cytotoxic agents |
| 05/31/2006 | EP1270570B1 Amide compounds and use thereof |
| 05/31/2006 | EP1251822A4 Novel coupler for use in oxidative hair dyeing |